Company / Assets per Share
Arbutus Biopharma Corp Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.50
FY2025
5-year range
$0.50 / $2.28
FY2021-FY2025
Trend
-35.8%
vs FY2024
Sector context
#207 of 210
Health Care
What the data says
Among 210 Health Care companies, Arbutus Biopharma Corp is in the bottom 1% for assets per share. Assets per Share has declined for 4 consecutive years, from $2.28 in FY2021 to $0.50 in FY2025.
Based on SEC 10-K filings.
0.50 in FY2025 with a 5-year CAGR of -25.1%.
Declined from $0.92 to $0.50 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -28.2%
- 5-Year CAGR
- -25.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 210This company $0.50 Sector average $353.15
▼
-99.9% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 35.8% year-over-year.
- Ranks #207 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.50 | -35.8% |
| FY2024 | $0.78 | -15.5% |
| FY2023 | $0.92 | -32.0% |
| FY2022 | $1.35 | -40.9% |
| FY2021 | $2.28 | +7.8% |
| FY2020 | $2.12 | +11.3% |
| FY2019 | $1.90 | -54.1% |
| FY2018 | $4.14 | -3.9% |
| FY2017 | $4.31 | -14.4% |
| FY2016 | $5.03 | -61.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026